Glucotrack Inc

For the period ended Jun 30, 2024. Filed Aug 13, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 13, 2024

GCTK$1.39-32.2%Stored close · as of Oct 29, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(in thousands of US dollars except share data)

	June 30, 2024	December 31, 2023
Unaudited
ASSETS
Current assets
Cash and cash equivalents	159	4,492
Other current assets	283	376
Total current assets	442	4,868
Operating lease right-of-use asset, net (Note 3C)	71	-
Property and equipment, net	86	27
Restricted cash	9	10
TOTAL ASSETS	608	4,905
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	2,736	839
Notes payable (Note 3F)	12	-
Operating lease liability, current (Note 3F)	25	-
Other current liabilities	887	673
Total current liabilities	3,660	1,512
Non-current liabilities
Loans from stockholders	191	196
Operating lease liability, non-current (Note 3F)	46	-
Total liabilities	3,897	1,708
Commitments and contingent liabilities (Note 4)	-
Stockholders’ equity
Common Stock of $ 0.001 par value (“Common Stock”):
100,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 5,478,436 and 4,178,274 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	5	4
Additional paid-in capital	113,903	112,982
Receipts on account of shares	50	48
Accumulated other comprehensive income	22	16
Accumulated deficit	(117,269)	(109,853)
Total stockholders’ equity (deficit)	(3,289)	3,197
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	608	4,905

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.